Crisaborole | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Crisaborole
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Crisaborole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 11 USDMF, 5 EU WC, 11 NDC API, 24 Listed Suppliers, $ API Reference Price

33 API Suppliers
11 USDMF
5 EU WC
11 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 2 FDA Orange Book, 1 Canada, 2 South Africa

5 FDF Dossiers
2 FDA Orange Book
1 Canada
2 South Africa

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Nanjing Well Pharmaceutical, 2 BASF, 1 CD Formulation, 1 Finar, 1 Valens Pharmachem

1 DKSH
1 Nanjing Well Pharmaceutical
2 BASF
1 CD Formulation
1 Finar
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

6 Topical, 5 Solubilizers, 2 Film Formers & Plasticizers, 2 Thickeners and Stabilizers, 1 Coating Systems & Additives, 1 Emulsifying Agents, 1 Controlled & Modified Release, 1 Parenteral

6 Topical
5 Solubilizers
2 Film Formers & Plasticizers
2 Thickeners and Stabilizers
1 Coating Systems & Additives
1 Emulsifying Agents
1 Controlled & Modified Release
1 Parenteral

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Annual Reports

1 US Medicaid Prescriptions
3 Annual Reports

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 4 Health Canada Patents

8 US Patents
1 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 3,579 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Pfizer Canada ULC

filter Patent Reset all filters

4 All

01 12597982

02 12642583

03 12949614

04 13023851

filter Product Reset all filters

4 All

01 4CRISABOROLE

filter Dosage Reset all filters

4 All

01 4OINTMENT

filter Exp Date Reset all filters

4 All

01 12026-02-16

02 12027-02-16

03 12036-11-25

04 12037-05-09

Virupaksha Crisaborole

Product Main Page

01

Pfizer Canada ULC

Crisaborole

CPhI Korea

Not Confirmed

Pfizer Canada ULC

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-16

Date Granted : 2014-07-08

Crisaborole

Brand Name : EUCRISA

Patent Number : 2597982

Filing Date : 2006-02-16

Strength per Unit : 2% w / w

Dosage Form : OINTMENT

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2026-02-16

Date Granted : 2014-07-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Pfizer Canada ULC

Crisaborole

CPhI Korea

Not Confirmed

Pfizer Canada ULC

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-02-16

Date Granted : 2016-08-23

Crisaborole

Brand Name : EUCRISA

Patent Number : 2642583

Filing Date : 2007-02-16

Strength per Unit : 2% w / w

Dosage Form : OINTMENT

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2027-02-16

Date Granted : 2016-08-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Pfizer Canada ULC

Crisaborole

CPhI Korea

Not Confirmed

Pfizer Canada ULC

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-05-09

Date Granted : 2021-01-26

Crisaborole

Brand Name : EUCRISA

Patent Number : 3023851

Filing Date : 2017-05-09

Strength per Unit : 2% w / w

Dosage Form : OINTMENT

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2037-05-09

Date Granted : 2021-01-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Pfizer Canada ULC

Crisaborole

CPhI Korea

Not Confirmed

Pfizer Canada ULC

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-25

Date Granted : 2021-06-15

Crisaborole

Brand Name : EUCRISA

Patent Number : 2949614

Filing Date : 2016-11-25

Strength per Unit : 2% w / w

Dosage Form : OINTMENT

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2036-11-25

Date Granted : 2021-06-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!